Corbus Pharmaceuticals Holdings Financial Statements 2012-2025 | CRBP

Revenue

$0.882

$3.937

$36.144

$4.822

$2.44

$1.911

$0.648

Cost Of Goods Sold

Gross Profit

$0.882

$3.937

$36.144

$4.822

$2.44

$1.911

$0.648

Research And Development Expenses

$32.222

$31.168

$16.137

$36.445

$98.267

$89.605

$48.614

$26.039

$15.437

$5.889

SG&A Expenses

$16.499

$13.91

$18.699

$20.425

$28.48

$23.643

$12.956

$8.964

$6.46

$3.613

Other Operating Income Or Expenses

$-5

Operating Expenses

Operating Income

$-48.721

$-45.078

$-39.836

$-55.989

$-122.81

$-77.105

$-56.748

$-32.563

$-19.985

$-8.854

Total Non-Operating Income/Expense

$8.512

$0.474

$-2.512

$10.349

$11.541

$5.651

$1.076

$0.141

$-0.014

$0.003

Pre-Tax Income

$-40.209

$-44.604

$-42.347

$-45.64

$-111.269

$-71.454

$-55.672

$-32.422

$-19.999

$-8.851

Income Taxes

Income After Taxes

$-40.209

$-44.604

$-42.347

$-45.64

$-111.269

$-71.454

$-55.672

$-32.422

$-19.999

$-8.851

Other Income

Income From Continuous Operations

$-40.209

$-44.604

$-42.347

$-45.64

$-111.269

$-71.454

$-55.672

$-32.422

$-19.999

$-8.851

Income From Discontinued Operations

Net Income

$-40.209

$-44.604

$-42.347

$-45.64

$-111.269

$-71.454

$-55.672

$-32.422

$-19.999

$-8.851

EBITDA

$-51.064

$-44.119

$-38.205

$-52.951

$-120.825

$-75.875

$-56.254

$-32.307

$-19.897

$-8.81

EBIT

$-48.721

$-45.078

$-39.836

$-55.989

$-122.81

$-77.105

$-56.748

$-32.563

$-19.985

$-8.854

Basic Shares Outstanding

Shares Outstanding

Basic EPS

$-3.68

$-10.31

$-10.15

$-11.15

$-42.64

$-33.63

$-29.43

$-19.52

$-14.71

$-8.41

EPS - Earnings Per Share

$-3.68

$-10.31

$-10.15

$-11.15

$-42.64

$-33.63

$-29.43

$-19.52

$-14.71

$-8.41